The small biotech stock soared thanks to a big deal with a big pharma company.
Voyager Therapeutics shares made an incredible gain on Friday after the firm announced a collaboration with pharma giant AbbVie.
Voyager Therapeutics stock soars on AbbVie pact worth potentially $1 billion
This week Merck (NYSE:MRK) announced a definitive agreement to buy late-stage immunotherapy company Immune Design Corp. (NASDAQ:IMDZ) for approximately $300 million. Its PD-L1...
AbbVie Inc. (NYSE:ABBV) announced that the FDA has accepted its new drug application (NDA) for its oral investigational JAK inhibitor, upadacitinib, and also granted a priority...
Roche (OTC:RHHBY) announced that the FDA has accepted the company’s Biologics License Application (BLA) for anti-CD79b antibody drug conjugate (ADC) polatuzumab vedotin in...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Sell||Sell||Sell||Strong Sell||Neutral|
|Technical Indicators||Strong Sell||Neutral||Strong Buy||Sell||Strong Sell|
|Summary||Strong Sell||Neutral||Neutral||Strong Sell||Sell|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Harami Cross Bearish||5H||Current|
|Bullish doji Star||1W||3||Jan 27, 2019|
|Falling Three Methods||1M||4||Oct 18|
|Morning Doji Star||1M||6||Aug 18|
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).Read More
|U.S. Commodity Futures Trading Commission (United States)||$250||Start Trading|
|U.S. Commodity Futures Trading Commission (United States)||Start Trading|
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.